PARSIPPANY, N.J., Nov. 29, 2017 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted Ferring Pharmaceuticals Inc. approval to market CLENPIQ™ (sodium picosulfate, magnesium oxide, ...

The prescribing information for Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid; Ferring) has been updated to include use in pediatric patients ≥9 years old for cleansing of ...

Clenpiq is indicated for cleansing of the colon as a preparation for colonoscopy in adults. Ferring announced the availability of Clenpiq (sodium picosulfate, magnesium oxide, anhydrous citric acid) ...

Please provide your email address to receive an email when new articles are posted on . “Many patients see colonoscopies as an ordeal they must endure for their overall health,” Lawrence Hookey, MD, ...

Generic drugmaker Lupin Inc’s instructions for using its proposed colonoscopy-prep solution do not induce patients or physicians to infringe Ferring Pharmaceuticals' patent on administering name-brand ...